Skip to content

Advertisement

  • Meeting abstract
  • Open Access

Redox alterations of platelets and erythrocytes represent progression marker and pathogenetic determinants in Kawasaki disease

  • Elisabetta Straface1Email author,
  • Donatella Pietraforte2,
  • Lucrezia Gambardella1,
  • Domenico Del Principe1,
  • Alessandra Marchesi3,
  • Marina Viora1,
  • Isabella Tarissi De Jacobis3,
  • Alberto Villani3 and
  • Walter Malorni1
Italian Journal of Pediatrics201541(Suppl 2):A69

https://doi.org/10.1186/1824-7288-41-S2-A69

Published: 30 September 2015

Keywords

Annexin VersusKawasaki DiseaseReactive Oxidize SpeciesKawasaki Disease PatientCoronary Artery Abnormality

Background

Kawasaki disease (KD) is a rare generalized systemic vasculitis of unknown etiology in which the main complication is the development of coronary artery abnormalities. Considering that an inflammation-associated systemic pro-oxidant status could play a critical pathogenetic role in KD progression [1], we evaluated some peripheral blood redox-associated parameters, including redox and aging features associated with red blood cells (RBCs) and platelets (PLT) integrity as possible pathogenetic determinants or progression markers in KD disease.

Materials and methods

The 18 KD patients, aged between 6 and 24 mounts, were recruited from the Bambino Gesù Hospital (BGH) of Rome (Italy) and studied, after obtaining the parent informed consent, before to start therapy with intravenous immunoglobulin and aspirin. Ten age-matched healthy donors (HD) were enrolled as controls. The study was approved by the BGH Institutional Review Board.

Morphological, biophysical, biochemical and flow cytometrical methods were used to evaluate: i) reactive oxidizing species (ROS) formation and oxidative stress-related biomarkers [3-nitrotyrosine, the endothelial nitric oxide synthase inhibitor, asymmetric dymethylarginine (ADMA), the pro-oxidant enzyme myeloperoxidase (MPO)]; ii) PLT integrity and function, including PLT activation and procoagulant state (annexin V positivity); iii) RBCs homeostasis, including RBC aging markers (glycophorin A and CD47 expression, annexin V positivity).

Results

With respect to HD, peripheral blood of KD patients showed increased levels of O2·, ·NO, 3-nitrotyrosine and MPO, and decreased ADMA concentration (Figure 1). In RBCs, alterations of biomarkers correlated with cell aging and death (i.e., decreased glycophorin A and CD47 expression, increased percentage of annexin V positive cells) [2] occurred. Interestingly, we found that two different PLT sub-populations seem to coexist in the KD peripheral blood (Figure 1): i) annexin V positive PLT, showing loss of mitochondrial membrane potential (considered as pro-coagulant) and ii) annexin V negative PLT, showing mitochondrial membrane hyperpolarization (non-pro-coagulant per se). These two sub-populations may considerably affect the coagulation cascade and inflammatory responses in KD patients [3].

Conclusions

These results lead us to hypothesize that the oxidative/nitrative stress occurring in KD inflamed blood vessels could alter both RBCs and PLT homeostasis, resulting in a sort of premature aging in these circulating cells that could lead to anemia and the formation of blood clots. These alterations could play a pathogenetic role in the cardiovascular complications often associated with KD but, in addition, the possible use of these data as real time biomarkers of progression cannot be ruled out.

Declarations

Acknowledgements

We thank Rosa Vona for technical assistance.

Authors’ Affiliations

(1)
Department of Therapeutic Research and Medicine Evaluation, Istituto Superiore di Sanità, Rome, Italy
(2)
Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy
(3)
General Pediatric and Infectious Disease Unit, Internal Care Department, Bambino Gesù Children's Hospital, Rome, Italy

References

  1. Cheung YF, K O, Woo CW, Armstrong S, Siow YL, Chow PC, et al: Oxidative stress in children late after Kawasaki disease: relationship with carotid atherosclerosis and stiffness. BMC Pediatr. 2008, 8: 20-10.1186/1471-2431-8-8.PubMedPubMed CentralView ArticleGoogle Scholar
  2. Straface E, Marchesi A, Gambardella L, Metere A, Tarissi de Jacobis I, Viora M, et al: Does oxidative stress play a critical role in cardiovascular complications of Kawasaki disease?. Antioxid Redox Signal. 2012, 17 (10): 1441-1446. 10.1089/ars.2012.4660.PubMedView ArticleGoogle Scholar
  3. Pietraforte D, Gambardella L, Marchesi A, Tarissi de Jacobis I, Villani A, Del Principe D, et al: Platelets in Kawasaki patients: two different populations with different mitochondrial functions. Int J Cardiol. 2014, 172 (2): 526-528. 10.1016/j.ijcard.2014.01.022.PubMedView ArticleGoogle Scholar

Copyright

© Straface et al. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement